This California-Based Biotech Found Massive Success Following DSMB Approval
2025年1月15日 - 3:40AM
AllPennyStocks.com
A California-based biotech company is turning
heads during Tuesday’s session after the company announced its
phase 2b COVID-19 trial received Independent Data Safety...
To read the full story on AllPennyStocks.com, click
here.
Vaxart (NASDAQ:VXRT)
過去 株価チャート
から 12 2024 まで 1 2025
Vaxart (NASDAQ:VXRT)
過去 株価チャート
から 1 2024 まで 1 2025
